CD44, a marker for prostate cancer stem cells, is reportedly suppressed by miR-141/200/429, thus prostate cancer samples and cell lines with high CD44 feature very low levels of miR-141/-200/-429. This evidence concerns the gene CD44 and prostate carcinoma.